Massimo Campieri

16.9k total citations · 4 hit papers
227 papers, 12.3k citations indexed

About

Massimo Campieri is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Massimo Campieri has authored 227 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 142 papers in Genetics, 104 papers in Epidemiology and 73 papers in Surgery. Recurrent topics in Massimo Campieri's work include Inflammatory Bowel Disease (142 papers), Microscopic Colitis (96 papers) and Helicobacter pylori-related gastroenterology studies (28 papers). Massimo Campieri is often cited by papers focused on Inflammatory Bowel Disease (142 papers), Microscopic Colitis (96 papers) and Helicobacter pylori-related gastroenterology studies (28 papers). Massimo Campieri collaborates with scholars based in Italy, United Kingdom and United States. Massimo Campieri's co-authors include Paolo Gionchetti, Fernando Rizzello, Gilberto Poggioli, Patrizia Brigidi, Mario Miglioli, Alessandro Venturi, Gabriele Bazzocchi, Andrea Belluzzi, C. Brignola and Beatrice Vitali and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Massimo Campieri

223 papers receiving 11.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: A double-blind, placebo-controlled trial

2000 1.1k citations Paolo Gionchetti, Fernando Rizzello et al. profile →
Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial

2003 794 citations Paolo Gionchetti, Fernando Rizzello et al. profile →
VSL#3 Probiotic-Mixture Induces Remission in Patients with Active Ulcerative Colitis

2005 552 citations Paolo Gionchetti, Massimo Campieri et al. profile →
Effect of an Enteric-Coated Fish-Oil Preparation on Relapses in Crohn's Disease

1996 546 citations Andrea Belluzzi, Massimo Campieri et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Massimo Campieri	6.4k	4.3k	3.8k	3.2k	2.8k	227	12.3k
Paolo Gionchetti	8.1k 1.3×	5.4k 1.2×	3.5k 0.9×	4.0k 1.2×	2.6k 0.9×	268	13.8k
Philippe Seksik	6.3k 1.0×	4.7k 1.1×	7.4k 2.0×	3.1k 1.0×	2.0k 0.7×	191	14.5k
Fernando Rizzello	4.0k 0.6×	2.4k 0.6×	2.7k 0.7×	1.9k 0.6×	2.2k 0.8×	185	7.8k
Raanan Shamir	4.0k 0.6×	5.4k 1.3×	2.5k 0.7×	4.5k 1.4×	2.0k 0.7×	407	16.9k
Ailsa Hart	5.6k 0.9×	3.9k 0.9×	4.0k 1.1×	3.5k 1.1×	1.1k 0.4×	327	12.6k
Eduard F. Stange	8.3k 1.3×	6.0k 1.4×	5.1k 1.4×	5.4k 1.7×	1.6k 0.6×	300	18.4k
Levinus A. Dieleman	3.7k 0.6×	2.1k 0.5×	3.8k 1.0×	2.0k 0.6×	1.3k 0.5×	180	9.4k
Daisy Jonkers	2.4k 0.4×	2.3k 0.5×	6.4k 1.7×	2.5k 0.8×	1.4k 0.5×	238	13.1k
Herbert Lochs	3.6k 0.6×	3.4k 0.8×	3.0k 0.8×	3.9k 1.2×	673 0.2×	262	15.6k
Pierre Desreumaux	3.8k 0.6×	2.7k 0.6×	5.1k 1.3×	2.9k 0.9×	843 0.3×	269	13.4k

Countries citing papers authored by Massimo Campieri

Since Specialization

Citations

This map shows the geographic impact of Massimo Campieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Campieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Campieri more than expected).

Fields of papers citing papers by Massimo Campieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Campieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Campieri. The network helps show where Massimo Campieri may publish in the future.

Co-authorship network of co-authors of Massimo Campieri

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Campieri. A scholar is included among the top collaborators of Massimo Campieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Campieri. Massimo Campieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gionchetti, Paolo, Carlo Calabrese, R. Tambasco, et al.. (2012). Probiotics, Prebiotics and Antibiotics in the Treatment of Inflammatory Bowel Disease. Journal of Gastroenterology and Hepatology Research. 1(6). 97–106. 4 indexed citations

Brigidi, Patrizia, Paolo Gionchetti, Beatrice Vitali, et al.. (2012). Probiotic bacterial DNA induces interleukin-10 production by human dendritic cells via toll-like receptor-9. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 7(1). 2 indexed citations

Agostini, Alessandro, Fernando Rizzello, Paolo Gionchetti, et al.. (2010). Parental Bonding and Inflammatory Bowel Disease. Psychosomatics. 51(1). 14–21. 28 indexed citations

Calabrese, Carlo, Enzo Spisni, Giuseppina Liguori, et al.. (2010). Potential role of the cannabinoid receptor CB₁ in the pathogenesis of erosive and non‐erosive gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics. 32(4). 603–611. 8 indexed citations

Poggioli, Gilberto, Silvio Laureti, Massimo Campieri, et al.. (2007). Infliximab in the treatment of Crohn's disease. Therapeutics and Clinical Risk Management. 3(2). 301–308. 33 indexed citations

Gionchetti, Paolo, Agesilao D’Arienzo, Fernando Rizzello, et al.. (2005). Topical Treatment of Distal Active Ulcerative Colitis With Beclomethasone Dipropionate or Mesalamine. Journal of Clinical Gastroenterology. 39(4). 291–297. 45 indexed citations

Hart, Ailsa, MA Kamm, Patrizia Brigidi, et al.. (2004). DNA derived from probiotic bacteria modulates human dendritic cell phenotype and function. Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna). 1 indexed citations

Muratori, P., Luigi Muratori, M. Guidi, et al.. (2003). Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clinical & Experimental Immunology. 132(3). 473–476. 81 indexed citations

Campieri, Massimo. (2002). New steroids and new salicylates in inflammatory bowel disease: a critical appraisal: Table 1. Gut. 50(suppl 3). iii43–iii46. 40 indexed citations

10.

Campieri, Massimo, et al.. (2001). Bacteria as the cause of ulcerative colitis. Gut. 48(1). 132–135. 166 indexed citations

11.

Uguccioni, Mariagrazia, Paolo Gionchetti, Davide F. Robbiani, et al.. (1999). Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis. American Journal Of Pathology. 155(2). 331–336. 229 indexed citations

12.

Gionchetti, Paolo, Fernando Rizzello, A. Venturi, et al.. (1998). Comparison of oral with rectal mesalazine in the treatment of ulcerative proctitis. Diseases of the Colon & Rectum. 41(1). 93–97. 109 indexed citations

13.

Gionchetti, Paolo, Maurizio Vecchi, Fernando Rizzello, et al.. (1997). Lack of effect of antineutrophil cytoplasmic antibodies associated with ulcerative colitis on superoxide anion production from neutrophils.. Gut. 40(1). 102–104. 16 indexed citations

14.

Campieri, Massimo, et al.. (1997). Oral budesonide is as effective as oral prednisolone in active Crohn’s disease. Gut. 41(2). 209–214. 259 indexed citations

15.

Campieri, Massimo. (1996). What is the best initial treatment and maintenance therapy for distal ulcerative colitis?. Inflammatory Bowel Diseases. 2(4). 306–307. 1 indexed citations

16.

Gionchetti, Paolo, Massimo Campieri, Andrea Belluzzi, et al.. (1994). Bioavailability of single and multiple doses of a new oral formulation of 5‐ASA in patients with inflammatory bowel disease and healthy volunteers. Alimentary Pharmacology & Therapeutics. 8(5). 535–540. 18 indexed citations

17.

Belluzzi, Andrea, C. Brignola, Massimo Campieri, et al.. (1994). Short report: zinc sulphate supplementation corrects abnormal erythrocyte membrane long‐chain fatty acid composition in patients with Crohn's disease. Alimentary Pharmacology & Therapeutics. 8(1). 127–130. 8 indexed citations

18.

Campieri, Massimo, Giuseppe Brunetti, M. Miglioli, et al.. (1989). Topical treatment with 5-ASA supositories in distal ulcerative colitis. A randomized double blind placebo controlled study with Asacol suppositories. An Italian co-operative study group. 21. 15–16. 1 indexed citations

19.

Campieri, Massimo, Giorgio Assuero Lanfranchi, Silvia Boschi, et al.. (1985). Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.. Gut. 26(4). 400–405. 54 indexed citations

20.

Lanfranchi, Giorgio Assuero, Gabriele Bazzocchi, C. Brignola, Massimo Campieri, & G Labò. (1984). Different patterns of intestinal transit time and anorectal motility in painful and painless chronic constipation.. Gut. 25(12). 1352–1357. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact